Hoertkorn Richard Charles Pfizer Inc Transaction History

Hoertkorn Richard Charles

$192 Million
Q3 2025

A detailed history of Hoertkorn Richard Charles transactions in Pfizer Inc stock. As of the latest transaction made, Hoertkorn Richard Charles holds 12,784 shares of PFE stock, worth $320,622. This represents 0.17% of its overall portfolio holdings.

Number of Shares

12,784

Previous 5,234 144.25%

Holding current value

$320,622

Previous $126,000 157.94%

% of portfolio

0.17%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$23.29 - $25.88 $175,839 - $195,394	7,550 Added 144.25%	12,784 $325,000
Q1 2025 Apr 24, 2025	SELL	$25.01 - $27.13 $2,576 - $2,794	-103 Reduced 1.93%	5,234 $132,000
Q4 2024 Feb 12, 2025	SELL	$24.8 - $30.19 $14,185 - $17,268	-572 Reduced 9.68%	5,337 $141,000
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $55,732 - $63,156	-2,012 Reduced 25.4%	5,909 $171,000
Q2 2024 Jul 22, 2024	SELL	$25.26 - $29.6 $6,719 - $7,873	-266 Reduced 3.25%	7,921 $221,000

Q1 2024 May 02, 2024	SELL	$25.89 - $29.73 $2,589 - $2,973	-100 Reduced 1.21%	8,187 $227,000
Q4 2023 Feb 15, 2024	SELL	$26.13 - $33.94 $26,130 - $33,940	-1,000 Reduced 10.77%	8,287 $238,000
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $3,209 - $3,751	-100 Reduced 1.07%	9,287 $308,000
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $525 - $641	12 Added 0.13%	9,387 $411,000
Q2 2022 Jul 15, 2022	SELL	$46.53 - $55.17 $37,224 - $44,136	-800 Reduced 7.86%	9,375 $491,000
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $20,587 - $25,510	-450 Reduced 4.24%	10,175 $527,000
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $1,962 - $2,521	-50 Reduced 0.47%	10,625 $457,000
Q2 2021 Jul 12, 2021	SELL	$35.91 - $40.68 $25,136 - $28,476	-700 Reduced 6.15%	10,675 $418,000
Q1 2021 Apr 21, 2021	SELL	$33.49 - $37.77 $16,745 - $18,885	-500 Reduced 4.21%	11,375 $412,000
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $7,530 - $9,135	-250 Reduced 2.06%	11,875 $388,000
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $12,839 - $18,344	-475 Reduced 3.77%	12,125 $396,000
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $69,955 - $79,390	-2,125 Reduced 14.43%	12,600 $494,000
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $189,254 - $245,407	-5,825 Reduced 28.35%	14,725 $529,000
Q2 2019 Jul 09, 2019	SELL	$36.98 - $41.52 $28,659 - $32,178	-775 Reduced 3.63%	20,550 $890,000
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $35,625 - $39,140	-950 Reduced 4.26%	21,325 $906,000
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $50,011 - $57,018	-1,300 Reduced 5.51%	22,275 $972,000
Q3 2018 Oct 18, 2018	SELL	$34.47 - $41.81 $17,235 - $20,905	-500 Reduced 2.08%	23,575 $1.04 Million
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $100,588 - $107,237	-3,050 Reduced 11.24%	24,075 $873,000
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $210,606 - $244,332	-6,600 Reduced 19.57%	27,125 $963,000
Q4 2017 Jan 25, 2018	SELL	$33.26 - $35.29 $8,315 - $8,822	-250 Reduced 0.74%	33,725 $1.22 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $1.05 Million - $1.16 Million	33,975	33,975 $1.21 Million

Others Institutions Holding PFE

# of Institutions

3,372

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoertkorn Richard Charles, based on Form 13F filings with the SEC.

News

Stay updated on Hoertkorn Richard Charles with notifications on news.

Account

Hoertkorn Richard Charles Pfizer Inc Transaction History